Logo image of CGX-DB-B.CA

CINEPLEX INC (CGX-DB-B.CA) Stock Fundamental Analysis

TSX:CGX-DB-B - Toronto Stock Exchange - CA172454AC48 - Currency: CAD

128  -4.5 (-3.4%)

Fundamental Rating

3

Overall CGX-DB-B gets a fundamental rating of 3 out of 10. We evaluated CGX-DB-B against 13 industry peers in the Entertainment industry. While CGX-DB-B is still in line with the averages on profitability rating, there are concerns on its financial health. CGX-DB-B is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

CGX-DB-B had negative earnings in the past year.
CGX-DB-B had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: CGX-DB-B reported negative net income in multiple years.
CGX-DB-B had a positive operating cash flow in 4 of the past 5 years.
CGX-DB-B.CA Yearly Net Income VS EBIT VS OCF VS FCFCGX-DB-B.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M -600M

1.2 Ratios

The Return On Assets of CGX-DB-B (-1.65%) is comparable to the rest of the industry.
With a decent Return On Invested Capital value of 3.64%, CGX-DB-B is doing good in the industry, outperforming 75.00% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for CGX-DB-B is in line with the industry average of 3.64%.
The 3 year average ROIC (3.36%) for CGX-DB-B is below the current ROIC(3.64%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -1.65%
ROE N/A
ROIC 3.64%
ROA(3y)1.91%
ROA(5y)-6.6%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)3.36%
ROIC(5y)N/A
CGX-DB-B.CA Yearly ROA, ROE, ROICCGX-DB-B.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K -2K -2.5K

1.3 Margins

With an excellent Operating Margin value of 6.58%, CGX-DB-B belongs to the best of the industry, outperforming 91.67% of the companies in the same industry.
CGX-DB-B's Operating Margin has declined in the last couple of years.
CGX-DB-B's Gross Margin of 67.02% is amongst the best of the industry. CGX-DB-B outperforms 91.67% of its industry peers.
In the last couple of years the Gross Margin of CGX-DB-B has remained more or less at the same level.
Industry RankSector Rank
OM 6.58%
PM (TTM) N/A
GM 67.02%
OM growth 3YN/A
OM growth 5Y-3.58%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.02%
GM growth 5Y0.37%
CGX-DB-B.CA Yearly Profit, Operating, Gross MarginsCGX-DB-B.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150

More info and screens

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CGX-DB-B is destroying value.
CGX-DB-B has less shares outstanding than it did 1 year ago.
The number of shares outstanding for CGX-DB-B remains at a similar level compared to 5 years ago.
CGX-DB-B has a better debt/assets ratio than last year.
CGX-DB-B.CA Yearly Shares OutstandingCGX-DB-B.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
CGX-DB-B.CA Yearly Total Debt VS Total AssetsCGX-DB-B.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

An Altman-Z score of 2.01 indicates that CGX-DB-B is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.01, CGX-DB-B belongs to the top of the industry, outperforming 91.67% of the companies in the same industry.
CGX-DB-B has a debt to FCF ratio of 23.04. This is a negative value and a sign of low solvency as CGX-DB-B would need 23.04 years to pay back of all of its debts.
CGX-DB-B has a Debt to FCF ratio (23.04) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 23.04
Altman-Z 2.01
ROIC/WACC0.5
WACC7.21%
CGX-DB-B.CA Yearly LT Debt VS Equity VS FCFCGX-DB-B.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

2.3 Liquidity

A Current Ratio of 0.43 indicates that CGX-DB-B may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.43, CGX-DB-B is doing worse than 75.00% of the companies in the same industry.
CGX-DB-B has a Quick Ratio of 0.43. This is a bad value and indicates that CGX-DB-B is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.39, CGX-DB-B is not doing good in the industry: 75.00% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.43
Quick Ratio 0.39
CGX-DB-B.CA Yearly Current Assets VS Current LiabilitesCGX-DB-B.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

More info and screens

3

3. Growth

3.1 Past

CGX-DB-B shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -136.60%.
CGX-DB-B shows a decrease in Revenue. In the last year, the revenue decreased by -4.21%.
CGX-DB-B shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -4.39% yearly.
EPS 1Y (TTM)-136.6%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%137.59%
Revenue 1Y (TTM)-4.21%
Revenue growth 3Y26.54%
Revenue growth 5Y-4.39%
Sales Q2Q%15.13%

3.2 Future

Based on estimates for the next years, CGX-DB-B will show a very strong growth in Earnings Per Share. The EPS will grow by 112.61% on average per year.
The Revenue is expected to grow by 7.08% on average over the next years.
EPS Next Y280.65%
EPS Next 2Y112.61%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year10.75%
Revenue Next 2Y7.08%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CGX-DB-B.CA Yearly Revenue VS EstimatesCGX-DB-B.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B
CGX-DB-B.CA Yearly EPS VS EstimatesCGX-DB-B.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -2 -4 -6

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

CGX-DB-B reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
A Price/Forward Earnings ratio of 181.05 indicates a quite expensive valuation of CGX-DB-B.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CGX-DB-B indicates a somewhat cheap valuation: CGX-DB-B is cheaper than 66.67% of the companies listed in the same industry.
CGX-DB-B is valuated expensively when we compare the Price/Forward Earnings ratio to 22.70, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 181.05
CGX-DB-B.CA Price Earnings VS Forward Price EarningsCGX-DB-B.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 100 -100 -200

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CGX-DB-B is valued a bit cheaper than the industry average as 66.67% of the companies are valued more expensively.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CGX-DB-B is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 101.91
EV/EBITDA 37.18
CGX-DB-B.CA Per share dataCGX-DB-B.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20

4.3 Compensation for Growth

CGX-DB-B's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CGX-DB-B's earnings are expected to grow with 112.61% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y112.61%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

CGX-DB-B does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CINEPLEX INC

TSX:CGX-DB-B (2/20/2025, 7:00:00 PM)

128

-4.5 (-3.4%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)02-11 2025-02-11/amc
Earnings (Next)05-07 2025-05-07
Inst Owners28.77%
Inst Owner ChangeN/A
Ins Owners1.76%
Ins Owner ChangeN/A
Market Cap8.12B
Analysts78
Price Target163.53 (27.76%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-1.67%
Min Revenue beat(2)-4.6%
Max Revenue beat(2)1.26%
Revenue beat(4)2
Avg Revenue beat(4)-1.29%
Min Revenue beat(4)-4.6%
Max Revenue beat(4)1.26%
Revenue beat(8)5
Avg Revenue beat(8)-1.05%
Revenue beat(12)9
Avg Revenue beat(12)0.07%
Revenue beat(16)11
Avg Revenue beat(16)-0.86%
PT rev (1m)7.05%
PT rev (3m)3.26%
EPS NQ rev (1m)-420%
EPS NQ rev (3m)N/A
EPS NY rev (1m)-15.49%
EPS NY rev (3m)-18.6%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-1.18%
Revenue NY rev (3m)-0.46%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 181.05
P/S 6.1
P/FCF 101.91
P/OCF 50.11
P/B N/A
P/tB N/A
EV/EBITDA 37.18
EPS(TTM)-0.59
EYN/A
EPS(NY)0.71
Fwd EY0.55%
FCF(TTM)1.26
FCFY0.98%
OCF(TTM)2.55
OCFY2%
SpS20.98
BVpS-0.63
TBVpS-11.69
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.65%
ROE N/A
ROCE 5.05%
ROIC 3.64%
ROICexc 3.82%
ROICexgc 6.65%
OM 6.58%
PM (TTM) N/A
GM 67.02%
FCFM 5.99%
ROA(3y)1.91%
ROA(5y)-6.6%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)3.36%
ROIC(5y)N/A
ROICexc(3y)3.46%
ROICexc(5y)N/A
ROICexgc(3y)5.89%
ROICexgc(5y)N/A
ROCE(3y)4.66%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y2.1%
ROICexc growth 3YN/A
ROICexc growth 5Y0.06%
OM growth 3YN/A
OM growth 5Y-3.58%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.02%
GM growth 5Y0.37%
F-Score5
Asset Turnover0.58
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 23.04
Debt/EBITDA 6.58
Cap/Depr 46.28%
Cap/Sales 6.19%
Interest Coverage 0.72
Cash Conversion 61.03%
Profit Quality N/A
Current Ratio 0.43
Quick Ratio 0.39
Altman-Z 2.01
F-Score5
WACC7.21%
ROIC/WACC0.5
Cap/Depr(3y)39.73%
Cap/Depr(5y)33.4%
Cap/Sales(3y)5.83%
Cap/Sales(5y)8.44%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-136.6%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%137.59%
EPS Next Y280.65%
EPS Next 2Y112.61%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-4.21%
Revenue growth 3Y26.54%
Revenue growth 5Y-4.39%
Sales Q2Q%15.13%
Revenue Next Year10.75%
Revenue Next 2Y7.08%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-41.73%
EBIT growth 3YN/A
EBIT growth 5Y-7.81%
EBIT Next Year243.2%
EBIT Next 3Y53.39%
EBIT Next 5Y27.52%
FCF growth 1Y-45.32%
FCF growth 3Y41.4%
FCF growth 5Y-13.75%
OCF growth 1Y-22.53%
OCF growth 3Y38.48%
OCF growth 5Y-12.79%